Business Context and Reporting Period
Company: Synergy CHC Corp. (SNYR)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: Synergy is a consumer health care company focused on two marquee brands: FOCUSfactor (brain health supplements and RTD beverages) and Flat Tummy (lifestyle and wellness products). The company utilizes an asset-light model, partnering with third-party manufacturers and selling through major retailers (Costco, Walmart, Amazon) and direct-to-consumer channels. The company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Revenue | $30,380,809 | $34,834,243 |
| Gross Profit | $20,302,817 (67% margin) | $23,643,019 (68% margin) |
| Net Income (Loss) | $(12,341,208) | $2,124,976 |
| EBITDA | $(6,185,726) | $6,464,070 |
| Cash and Equivalents | $2,622,313 | $687,920 |
| Total Debt (Notes Payable) | $26,714,661 (net of discounts) | $27,515,346 (net of discounts) |
| Working Capital | $1,778,308 (Surplus) | $(1,124,601) (Deficit) |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by 12.8% ($4.45 million) primarily due to a reversal of $2.9 million in IP license revenue (terminated due to regional instability) and a shift in focus toward beverage development which saw lower sales volume compared to 2024.
- Significant Bad Debt Charge: The company recorded a $6.66 million reserve for bad debts in 2025, compared to zero in 2024. This included a $4.4 million write-off of a related-party loan receivable deemed uncollectible and $1.65 million in other uncollectible receivables.
- Operating Expenses: General and Administrative expenses increased by 87% ($4.1 million) due to higher professional fees, legal expenses, board costs, and the write-off of prepaid media credits. Selling and Marketing expenses remained relatively flat.
- Debt Restructuring: The company secured a new $17.5 million term loan in May 2025 to refinance existing debt, extending maturity dates to 2029. However, interest expense increased to $5.92 million due to higher rates and amortization of debt discounts.
Guidance, Outlook, and Risks
- Going Concern: Management identified conditions raising substantial doubt about the company's ability to continue as a going concern due to an accumulated deficit of $56.4 million and operating cash outflows. However, management concluded that recent capital raises ($3.7 million in 2025), debt restructuring, and cost-cutting measures (layoffs) alleviate this doubt for the next 12 months.
- Internal Controls: The company identified material weaknesses in internal controls over financial reporting, specifically regarding segregation of duties and defined roles in finance. Management is implementing remediation plans in 2026.
- Customer Concentration: The top two customers accounted for 79% of revenue in 2025. The loss of a major retailer would materially impact the business.
- Subsequent Events (Post-Dec 31, 2025):
- Costco notified the company of an overstock situation, pausing orders for promotional endcaps due to declining sales.
- A subordinated lender (Sanders Morris Harris) indicated they do not intend to extend the March 31, 2026 maturity date of their loan.
- Additional layoffs of 13 employees occurred in March 2026.
Investor Verification Checklist
- Debt Maturity Wall: Verify the status of the subordinated loan maturing March 31, 2026, and the company's ability to refinance or repay it given the recent Costco notification.
- Revenue Quality: Confirm the impact of the Costco inventory overstock on Q1 and Q2 2026 revenue projections.
- Internal Control Remediation: Review the progress of remediation for the identified material weaknesses in internal controls to ensure future financial reporting reliability.
- Liquidity Runway: Assess the sufficiency of the $2.6 million cash balance against weekly debt service obligations and operating burn rates.
- License Revenue Reversal: Understand the full extent of the $2.9 million revenue reversal and any potential legal or financial recourse regarding the terminated IP license.